Frank-D Böhmer Selected Research

Frank-D Böhmer Research Topics

Disease

13	Neoplasms (Cancer) 08/2022 - 07/2003
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2022 - 05/2005
3	Meningioma (Meningiomas) 01/2020 - 07/2011
3	Carcinogenesis 01/2020 - 12/2005
2	Carcinoma (Carcinomatosis) 05/2015 - 06/2006
2	Myocarditis (Carditis) 07/2008 - 04/2005
2	Fibrosis (Cirrhosis) 07/2008 - 04/2005
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 12/2016
1	Hepatocellular Carcinoma (Hepatoma) 05/2015
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 01/2013
1	Neointima 01/2010
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2010
1	Colonic Neoplasms (Colon Cancer) 10/2009
1	Diabetes Mellitus 07/2009
1	Squamous Cell Carcinoma of Head and Neck 07/2006
1	Vesicular Stomatitis 05/2005
1	Leukemia 01/2004

Drug/Important Bio-Agent (IBA)

6	Phosphotransferases (Kinase)IBA 01/2020 - 05/2005
6	fms-Like Tyrosine Kinase 3IBA 04/2017 - 05/2005
5	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2020 - 07/2011
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2011
3	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 05/2005
3	Protein Tyrosine PhosphatasesIBA 05/2015 - 07/2011
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2015 - 07/2003
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2011 - 07/2008
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2007 - 01/2004
2	Tyrosine Kinase InhibitorsIBA 02/2018 - 09/2010
2	Oncogene Proteins (Oncogene Protein)IBA 04/2017 - 12/2016
2	Imatinib Mesylate (Gleevec)FDA Link 09/2010 - 07/2008
1	Therapeutic UsesIBA 08/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2022
1	Neurofibromin 2 (Merlin)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2018
1	nilotinib FDA Link 02/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2016
1	Proteinase-Activated ReceptorsIBA 05/2015
1	6,8-difluoro-4-methylumbelliferyl phosphateIBA 05/2015
1	AntibodiesIBA 05/2015
1	CytokinesIBA 05/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2015
1	PAR-1 ReceptorIBA 05/2015
1	flt3 ligand protein (flt3 ligand)IBA 01/2013
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 07/2012
1	Tyrosine (L-Tyrosine)FDA Link 05/2012
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2012
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 05/2012
1	Mutant Proteins (Protein, Mutant)IBA 04/2011
1	Histone Deacetylase InhibitorsIBA 09/2010
1	beta-damascenoneIBA 10/2009
1	3-hydroxy-beta-damasconeIBA 10/2009
1	PolyphenolsIBA 10/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2009
1	Hydroxyproline (4 Hydroxyproline)IBA 07/2008
1	Platelet-Derived Growth FactorIBA 07/2008
1	platelet-derived growth factor AIBA 07/2008
1	TenascinIBA 07/2006
1	KalininIBA 07/2006
1	LigandsIBA 06/2006
1	Transforming Growth Factor alpha (TGF-alpha)IBA 06/2006
1	XenobioticsIBA 12/2005
1	Anticarcinogenic AgentsIBA 12/2005
1	EnzymesIBA 12/2005
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 12/2005
1	Glutathione (Reduced Glutathione)IBA 12/2005
1	TransferasesIBA 12/2005
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2005
1	platelet-derived growth factor C (PDGF-C)IBA 04/2005
1	prolylglycineIBA 09/2003

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2010
2	Lasers (Laser) 05/2015 - 07/2006
2	Heterologous Transplantation (Xenotransplantation) 05/2015 - 07/2011
2	Chemoprevention 10/2009 - 12/2005
1	Immunotherapy 01/2020
1	Stents 01/2010